Synonyms: RDEA-594 | RDEA594 | Zurampic®
lesinurad is an approved drug (FDA (2015), EMA (2016))
Compound class:
Synthetic organic
Comment: Lesinurad is an orally available inhibitor of URAT1, the renal transporter that regulates uric acid excretion from the body [1-2].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2015) | EMA (2016) |
IUPAC Name ![]() |
2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
9345 | lesinurad |
Synonyms ![]() |
RDEA-594 | RDEA594 | Zurampic® |
Database Links ![]() |
|
CAS Registry No. | 878672-00-5 (source: SciFinder) |
ChEMBL Ligand | CHEMBL2105720 |
DrugCentral Ligand | 5075 |
GtoPdb PubChem SID | 223366008 |
PubChem CID | 53465279 |
RCSB PDB Ligand | A1AIL |
Search Google for chemical match using the InChIKey | FGQFOYHRJSUHMR-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | FGQFOYHRJSUHMR |
Search PubMed clinical trials | lesinurad |
Search PubMed titles | lesinurad |
Search PubMed titles/abstracts | lesinurad |
UniChem Compound Search for chemical match using the InChIKey | FGQFOYHRJSUHMR-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FGQFOYHRJSUHMR-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Lesinurad (links to external site)
Cat. No. HY-15258 |